Share Option Award & PDMR Dealings
Share options awarded to CSO; CFO moved shares between personal and ISA accounts.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
Share Option Award:
IXICO plc (AIM: IXI), the medical imaging advanced analytics company delivering insights in neurosciences, today announces that it has issued a total of 500,000 options to subscribe for ordinary shares of 1 pence each in the Company (the "Share Options") to Robin Wolz, CSO and a PDMR of the Company.
In recognition of his increasing contribution to the continued success of the Group, the Board has decided to provide Mr Wolz with share option performance criteria that is aligned with the Group's Executive Directors.
The Share Options have vesting criteria aligned with retention and annual share price growth over 3 years. These options have an exercise price of £0.01 and will be subject to a hold period to the third anniversary of their award.
The achievement of share price growth each year shall be measured by calculating the 3-month average share price immediately prior to each anniversary of the option award. The growth performance can be met in full by an absolute compound share price growth of 40% over the three-year period or in part by a 40% share price growth as compared to the prior year. In the first year this shall be compared to a baseline price equivalent to the three-month average share price immediately prior to the CEO joining the Company on 19 August 2024.
It is further announced that 200,000 options awarded to Mr Wolz on 30 October 2024 lapsed in full with effect from 28 November 2024.
Director Bed & ISA Dealings:
In addition, the Company announces that it received notification on 4 December 2024, that Grant Nash, CFO and PDMR, sold 260,000 ordinary shares of 1p each in the Company and repurchased 260,000 ordinary shares into Mr Nash's ISA account. Following this transaction Mr Nash's beneficial interest in the Company's shares has not changed.
| a) | Name | Robin Wolz |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Scientific Officer and PDMR |
| b) | Initial notification /Amendment | Initial |
| a) | Name | IXICO plc |
| b) | LEI | 2138005M1F59O6HWSA97 |
| a) | Description of the financial instrument, type of instrument | Options over ordinary shares in IXICO plc |
| Identification code | ISIN: GB00BFXR4C20 | |
| b) | Nature of the transaction | Grant of Share Options |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| 1 pence | 500,000 | |
| d) | Aggregated information | |
| N/A - single transaction | ||
| - Aggregated volume | ||
| - Price | ||
| e) | Date of the transaction | 4 December 2024 |
| f) | Place of the transaction | Off Market Transaction |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Grant Nash |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Financial Officer and PDMR |
| b) | Initial notification /Amendment | Initial |
| a) | Name | IXICO plc |
| b) | LEI | 2138005M1F59O6HWSA97 |
| a) | Description of the financial instrument, type of instrument | Ordinary shares in IXICO plc |
| Identification code | ISIN: GB00BFXR4C20 | |
| b) | Nature of the transaction | Sale and purchase of ordinary shares |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| Sale at 12.000p | 260,000 | |
| Purchase at 12.015p | 260,000 | |
| d) | Aggregated information | |
| N/A | ||
| - Aggregated volume | ||
| - Price | ||
| e) | Date of the transaction | 4 December 2024 |
| f) | Place of the transaction | Off Market Transaction |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.